Join Us for a Live Interactive CME Webcast!
“Cross-Setting Strategies for Improved Identification, Diagnosis, and Management of Homozygous Hypercholesterolemia” will take place virtually on Wednesday, October 25, 2023 at 6:00 PM CT.
This webcast was organized for the ACC Great Plains, Iowa and Minnesota Chapters.
Program Overview
Homozygous familial hypercholesterolemia (HoFH) is a genetic disorder characterized by markedly elevated levels of low-density lipoprotein cholesterol (LDL-C), leading to premature cardiovascular disease. Affected individuals are typically less responsive or unresponsive to standard lipid-lowering therapies (ie, statins and PCSK9 inhibitors) and may benefit from treatments with alternative mechanisms of action, such as the recently FDA-approved ANGPTL3 inhibitor evinacumab. With this in mind, this program has been designed to educate clinicians about the prevalence of HoFH, the importance of HoFH screening, and the benefits and limitations of current therapies for lipid management in patients with the disease. The nationally recognized expert faculty will also provide practical advice to attendees, based on their personal success, regarding strategies that improve patient access to newer lipid-lowering therapies.
Target Audience
This educational activity has been designed for US cardiologists and internal medicine physicians, nurse practitioners, and physician assistants involved in the identi fication, diagnosis, and management of patients with HoFH.
Credit Designation
Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 CreditTM.
Faculty Presenter
Mary McGowan, MD
Assistant Professor of Medicine
Geisel School of Medicine at Dartmouth
Lipid Clinic & Lipid Research
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire
